Skip to main content
Premium Trial:

Request an Annual Quote

Variagenics Patents SNP Discovery Method

NEW YORK, June 6-Variagenics said today that it has been granted a U.S. patent for its computational method for SNP identification.


The patent, granted June 4, covers Variagenics' proprietary technique for discovering unknown polymorphisms in genes that appear to be relevant to disease. Their "sequence scanning" method allows company researchers to more easily distinguish SNPs from sequence data.


Variagenics, based in Cambridge, Mass., is a pharmacogenomic and diagnostic company. It plans to use the data generated from its SNP studies in improving drug development and creating new pharmacogenomic diagnostics.


For more information, see the patent.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.